Erratum: A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women (Breast Cancer Research and Treatment DOI: 10.1007/s10549-006-9264-2);A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women

Breast Cancer Research and Treatment

Volumn 101, Issue 1, 2007, Pages 73-81

  Singh, Virendra ^a   Rastogi, Neeraj ^b   Sinha, Ashima ^a   Kumar, Abhai ^a   Mathur, Neeraj ^a   Singh, Mahendra Pratap ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cytochrome P450 1A1; M1 and M3 genotype; M2 and M4 genotype; North Indian women; Single nucleotide polymorphism

Indexed keywords

ASPARAGINE; CYTOCHROME P450 1A1; ISOLEUCINE; THREONINE;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE ISOLATION; GENOTYPE; HUMAN; HYDROXYLATION; INDIA; MAJOR CLINICAL STUDY; PREMENOPAUSE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; BREAST TUMOR; CATALYSIS; CHI SQUARE DISTRIBUTION; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; RISK; RISK FACTOR;

ADULT; BREAST NEOPLASMS; CATALYSIS; CHI-SQUARE DISTRIBUTION; CYTOCHROME P-450 CYP1A1; FEMALE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 34247592963     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9421-7     Document Type: Erratum

References (39)

1. Mitrunen K, Hirvonen A (2003) Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in estrogen biosynthesis and metabolism. Mutat Res 544:9-41
2. McManus ME, Burgess WM, Veronese ME, Huggett A, Quattrochi LC, Tukey RH (1990) Metabolism of 2-acetyleaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochrome P-450. Cancer Res 50:3367-3376
3. Thompson PA, Ambrosone C (2000) Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J Natl Cancer Inst Monogr 27:125-134
4. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D (2000) Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J Natl Cancer Inst Monogr 27:75-93
5. Lakhani NJ, Sarkar MA, Venitz J, Figg WD (2003) 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 23:165-172
6. Brueggemeier RW, Bhat AS, Lovely CJ, Coughenour HD, Joomprabutra S, Weitzel DH, Vandre DD, Yusuf F, Burak WE Jr (200l) 2-Methoxyestradiol: a new 2-methoxyestrogen analog that exhibit antiproliferative activity and alters tubulin dynamics. J Steroid Biochem Mol Biol 78:145-156
7. Schneider J, Huh MM, Bradlow HL, Fishman J (1984) Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J Biol Chem 259:4840-4845
8. Fotsis T, Zhang Y, Pepper MS, Aldercreutz H, Montesano R, Nawroth PP, Schweilgerer L (1994) The endogenous estrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumor growth. Nature 368:237-239
9. Tabakovic K, Gleason WB, Ojala WH, Abdul-Hajj YJ (1996) Oxidative transformation of 2-hydroxyestrone. Stability and reactivity of 2,3-estrone quinone and its relationship to estrogen carcinogenicity. Chem Res Toxicol 9:860-865
10. Liehr JG, Ricc MJ (1996) 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci USA 93:3294-3296
11. Masson LF, Sharp L, Cotton SC, Little J (2005) Cytochrome P-4501A1 gene polymorphisms and risk of breast cancer: a HuGE review. Am J Epidemiol 161:901-915
12. Kawajiri K, Watanabe J, Gotoh O, Tagashira Y, Sogawa K, Fujii-Kuriyama Y (1986) Structure and drug inducibility of human cytochrome P-450c gene. Eur J Biochem 159:219-225
13. McKay JA, Murray GI, Ah-See AK, Greenlee WF, Marcus CB, Burke MD, Melvin WT (1996) Differential expression of CYP1A1 and CYP1B1 in human breast cancer. Biochem Soc Trans 24:327S
14. Boyapati SM, Shu XO, Gao YT, Cai Q, Jin F, Zheng W (2005) Polymorphism in CYP1A1 and breast carcinoma risk in a population based case-control study of Chinese women. Cancer 103:2228-2235
15. Okobia M, Bunker C, Zmuda J, Kammerer C, Vogel V, Uche E, Anyanwu S, Ezeome E, Ferrell R, Kuller L (2005) Cytochrome P4501A1 genetic polymorphisms and breast cancer risk in Nigerian Women. Breast Cancer Res Treat 94:285-293
16. Hefler LA, Tempfer CB, Grimm C, Lebrecht A, Ulbrich E, Heinze G, Leodolter S, Schneeberger C, Mueller MW Muendlein A, Koelbl H (2004) Estrogen-metabolizing gene polymorphism in the assessment of breast carcinoma risk and fibrodenema risk in Caucasian Women. Cancer 101:264-269
17. Modugno F, Zmuda JM, Potter D, Cai C, Ziv E, Cummings SR, Stone KL, Morin PA, Greene D, Cauley JA (2005) Estrogen metabolizing polymorphisms and breast cancer risk among older white women. Breast Cancer Res Treat 93:261-270
18. Kawajiri K, Nakach K, Imai K, Yoshii A, Shinoda N, Wanatabe J (1990) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P-4501A1 gene. FEBS Lett 263:131-133
19. Hayashi S, Wanatabe J, Nakachi K, Kawajiri K (1991) Genetic linkage of lung associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P-450 1A1 gene. J Biochem (Tokyo) 110:407-411
20. Crofts F, Cosma GN, Currie D, Taioli E, Toniolo P, Garte SJ (1993) A novel CYP1A1 gene polymorphism in African Americans. Carcinogenesis 14:1729-1731
21. Cascorbi I, Brockmoller J, Roots I (1996) A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res 56:4965-4969
22. Tailoi E, Bradlow HL, Garbers SV, Sepkovic DW, Osborne MP, Trachman J, Ganguly S, Garte SJ (1999) Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk. Cancer Detect Prev 23:232-237
23. Taioli E, Trachman J, Chen X, Toniolo P, Garte SJ (1995) A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African American women. Cancer Res 55:3757-3758
24. Rebbeck TR, Rosvold EA, Duggan DJ, Zhang J, Buetow KH (1994) Genetics of CYP1A1: coamplification of specific alleles by polymerase chain reaction and association with breast cancer. Cancer Epidemiol Biomarkers Prev 3:511-514
25. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, Laughlin R, Nemoto T, Michalek AM, Harrington A (1995) Cytochrome P4501A1 and glutathione-S-transferase (M1) genetic polymorphisms and postmenapusal breast cancer risk. Cancer Res 55:3483-3485
26. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16:1215
27. Li Y, Millikan RC, Bell DA, Cui L, Tse CK, Newman B, Conway K (2004) Cigarette smoking, Cytochrome P450 polymorphisms, and breast cancer among African-American and white women. Breast Cancer Res 6:R460-R473
28. Boyum A (1964) Separation of white blood cells. Nature 204:793-794
29. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
30. Fasco MJ, Treanor CP, Spivack S, Figge HL, Kaminsky LS (1995) Quantitative RNA-polymerase chain reaction - DNA analysis by capillary electrophoresis and laser induced fluorescence. Anal Biochem 224:140-147
31. 2 in cardiac myocytes. Biochem Biophys Res Commun 307:416-421
32. Roberta JP, Fouts JR (1980) A rapid method for assaying the metabolism of 7-Ethoxyresorufin by Microsomal Subcellular Fractions. Anal Biochem 107:150-155
33. Zhu K, Hunter S, Payne-Wilks K, Sutcliffe C, Bentfey C, Roland CL, Williams SM (2006) Potential differences in breast cancer risk factors based on CYP1A1 MspI and African-American-specific genotypes. Ethn Dis 16:207-215
34. Ishibe N, Hankinson SE, Colditz GA, Spiegelman D, Willett WC, Speizer FE, Kelsey KT, Hunter DJ (1998) Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer risk in the Nurses Health Study. Cancer Res 58:667-671
35. Bailey LR, Roodi N, Verrier CS, Yee CJ, Dupont WD, Parl FF (1998) Breast cancer and CYP1A1, GSTM1 and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res 58:65-70
36. Chacko P, Joseph T, Mathew BS, Rajan B, Pillai MR (2005) Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome. Mutation Research 581:153-163
37. Moysich KB, Shields PG, Freudenheim JL, Schisterman EF, Vena JE, Kostyniak P, Greizerstein H, Marshall JR, Graham S, Ambrosome CB (1999) Polychlorinated biphenyls, cytochrome p4501A1 polymorphism, and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 8:41-44
38. Cribb AE, Kinght MJ, Dryer D, Guernsey J, Hender K, Tesch M, Saleh TM (2006) Role of polymorphic human cytochrome p450 enzymes in estrone oxidation. Cancer Epidemiol Biomarkers Prev 15:551-558
39. Shen Y, Li DK, Wu J, Zhang Z, Gao E (2006) Joint effects of the CYP1A1 MspI, ER alpha, PvuII, and ER alpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China. Cancer Epidemiol Biomarkers Prev 15:342-347